To: Board of Supervisors
From: Anna Roth, Health Services Director
Report Title: Amendment to Purchase Order with Fisher Scientific Company L.L.C.
☒Recommendation of the County Administrator ☐ Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, an amendment purchase order #23666 with Fisher Scientific Company L.L.C. to increase the payment limit by $900,000 to a new payment limit of $2,800,000 for the purchase of reagents, urinalysis controls, supplies including small equipment and Triage Brain Natriuretic Peptide tests and other supplies as needed for the clinical laboratories at the Contra Costa Regional Medical Center (CCRMC) with no change to the original term of May 1, 2021 through April 30, 2026.
FISCAL IMPACT:
Approval of this action will result in additional expenditures of up to $900,000 and will be funded by Hospital Enterprise Fund I revenues.
BACKGROUND:
Fisher Healthcare is a division of Fisher Scientific Company L.L.C., focusing on the distribution of medical and laboratory products to healthcare providers and institutions. It offers a wide range of products and services designed for clinical and diagnostic laboratories, hospitals, and point-of-care testing environments.
Triage Brain Natriuretic Peptide (BNP) is a diagnostic test used to measure the levels of BNP in a patient's blood. BNP is a hormone produced by the heart in response to increased pressure, typically due to heart stress or heart failure. The test is commonly used in emergency settings to help diagnose heart failure and differentiate it from other conditions that may cause shortness of breath, such as chronic obstructive pulmonary disease (COPD).
On October 12, 2021, the Board of Supervisors approved item C.45 to execute purchase order #23666 with Fisher Scientific in an amount not to exceed $1,900,000 for the purchase of reagents supplies including small equipment and Triage BNP tests for the clinical laboratories at CCRMC and Contra Costa Health Centers for the period from May 1, 2021 through April 30,2026.
Clinical laboratories at CCRMC have been utilizing Fisher Scientific Company L.L.C. as a primary supplier for its medical supplies, with monthly expenditures amounting to approximately $50,000. To ensure continued support for patient care, it is necessary to allocate additional funds to cover the rising supply costs. On January 27, 2025, the Purchasing Agent approved the continued use of Fisher Scientific Company L.L.C.
CONSEQUENCE OF NEGATIVE ACTION:
If this action is not approved, CCRMC will not be able to proceed with the procurement of necessary medical supplies and equipment, which may impact patient care and the smooth operation of clinical services.